StockData
BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO) stock

BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30
$78.18+0.17 (+0.22%)

Close on Nov 19, 2026Market cap $15.23BP/E –Yield –

BridgeBio Pharma net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$56.71M–
Q3 FY2025Sep 30, 2025-$182.74M–

More BridgeBio Pharma figures

See a number that looks wrong?